Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 2, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

An Emergency-deployable Albumin-enhanced NLR Derived by Machine Learning Improves Risk Stratification in Lung Cancer:

Yunhua Zhao1, Jilong Wang2,3,4,5, Yubao He6

  • 1Department of Emergency Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, P.R. China.

In Vivo (Athens, Greece)
|June 30, 2026
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of predictive and concurrent validity of global leadership initiative on malnutrition nutritional risk screening using PNI, ALI, and GNRI as alternative tools in patients with cancer.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

NLR-fat/NLR-muscle mass grading system significantly predicts survival in cancer patients: a multicenter cohort study.

Cancer treatment and research communications·2026
Same author

Transcriptome-Guided Identification of Sarcosine as a Protective Metabolite in Experimental Colitis.

The Tohoku journal of experimental medicine·2026
Same author

Temperature-dependent ion migration underlies sequence-specific collapse of unstructured RNA.

Biophysical journal·2026
Same author

Nutrition impact symptoms and the risk of malnutrition, frailty, and sarcopenia in adults with cancer: A cross-sectional latent class analysis.

JPEN. Journal of parenteral and enteral nutrition·2026
Same author

PeptoBrush Enables Sustained Release of Auger Radiotherapeutic [<sup>125</sup>I]Iododeoxyuridine for Glioblastoma Treatment.

Biomacromolecules·2026
Same journal

Time-Dependent Inflammatory Cytokine Responses in a Human Fetal Membrane Dual-Compartment Model.

In vivo (Athens, Greece)·2026
Same journal

Impact of COVID-19 Vaccine Type on the Efficacy and Safety of Nivolumab in Patients With Metastatic Non-small-cell Lung Cancer: A Multicenter Study.

In vivo (Athens, Greece)·2026
Same journal

Nutritional Support for Treatment Continuity and Survival in Advanced Gastric Cancer: A Propensity Score-matched Study.

In vivo (Athens, Greece)·2026
Same journal

Efficacy of Switching from Prior Nonsteroidal Anti-inflammatory Drugs to Transdermal Diclofenac in Cancer Pain Management.

In vivo (Athens, Greece)·2026
Same journal

Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Attenuates the Aggressive Phenotype of Vulvar Squamous Cell Carcinoma Cells <i>In Vitro</i>.

In vivo (Athens, Greece)·2026
Same journal

Prognostic Value of Liver Function-based Scores in Hepatocellular Carcinoma Patients Undergoing Liver Transplantation.

In vivo (Athens, Greece)·2026
See all related articles
This summary is machine-generated.

A new albumin-enhanced neutrophil-to-lymphocyte ratio (aNLR) improves lung cancer prognosis prediction. This simple blood test offers better risk stratification than existing inflammatory markers for personalized survival assessment.

Area of Science:

  • Oncology
  • Biomarkers
  • Inflammation research

Background:

  • Systemic inflammation significantly impacts lung cancer prognosis.
  • Current blood-based inflammatory indices have limited ability to discriminate patient risk.
  • There is a need for improved prognostic tools in lung cancer management.

Purpose of the Study:

  • To develop a novel, albumin-enhanced inflammatory index for improved lung cancer risk stratification.
  • To integrate serum albumin levels with the neutrophil-to-lymphocyte ratio (NLR) using machine learning.
  • To validate the prognostic performance of the new index against conventional markers.

Main Methods:

  • Utilized a database of 1,576 lung cancer patients, split into training and validation cohorts.
  • Employed LASSO regression to identify key prognostic laboratory markers.
Keywords:
Lung cancerinflammatory biomarkersmachine learningrisk stratificationserum albumin

Related Experiment Videos

Last Updated: Jul 2, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

  • Developed an albumin-enhanced NLR (aNLR) score using a supervised machine-learning approach.
  • Assessed prognostic value through Cox models, Kaplan-Meier analysis, and time-dependent AUC.
  • Main Results:

    • LASSO identified lymphocyte count, albumin, and neutrophil count as dominant prognostic factors.
    • The derived aNLR score demonstrated significantly improved prognostic discrimination (C-index 0.727) compared to NLR (C-index 0.600).
    • High aNLR was consistently linked to worse survival, showing substantial clinical utility and improved predictive accuracy.

    Conclusions:

    • The albumin-enhanced NLR (aNLR) offers superior prognostic discrimination in lung cancer compared to traditional inflammatory indices.
    • This machine-learning derived index supports more individualized survival assessment for lung cancer patients.
    • aNLR represents a promising, simple blood-based biomarker for clinical application in oncology.